A Common Deworming Drug Slowed Drug-Resistant Lung Tumors in Mice When Paired with a Targeted Cancer Drug
Nature World News | 15.10.2026 15:02
A medicine used for decades to treat intestinal worms slowed the growth of drug-resistant lung tumors in mice when it was given alongside a standard targeted cancer drug. The study, published Oct. 8 in PLOS ONE, tested the deworming drug mebendazole with gefitinib against a form of lung cancer that had stopped responding to gefitinib alone.
